# MET Crusaders

Free global support and navigation group for people with MET-altered cancer, including MET exon 14 skipping and MET amplification, and their care partners.

Author: Kevin Wimer
Canonical URL: https://kevinwimer.com/companies/met-crusaders/
Stable ID: 0c25ed07-3335-410d-a124-f20e797a977c
Revision: ba74d482-3b75-4931-9717-63e164a217fa
Published: 2026-10-25T03:12:58.825Z
Updated: 2026-10-25T03:12:58.825Z
Reviewed: 2026-10-22

## Who this is for
For patients and caregivers looking for community, education or help navigating care. Inclusion is not a recommendation or a finding that this group is right for your situation.

MET Crusaders is a global support group for people with any MET-altered cancer: MET exon 14 skipping, MET amplification, MET overexpression, in lung cancer or any other tumor type. It's part of ICAN, the International Cancer Advocacy Network, a Phoenix-based 501(c)(3) that has done patient navigation since 1996.

## What they offer

- Direct navigation of your case, including oncology nursing support.
- Second opinion referrals and help connecting to molecular testing.
- Clinical trial and compassionate use matching.
- MET Mentors, peer-to-peer support from other patients.
- Virtual meetings, webinars, social media groups and patient meet-ups.
- Plain-language recaps of MET research from big meetings like ASCO 2026.
- Training for patients who want to advocate, including on public policy.

## How to join and what it costs

As of October 2026, membership is free and includes their services. You join by calling or emailing them with your contact information (see Contacts).

## How it fits with other groups here

MET Crusaders is biomarker-specific. Its sister ICAN group for exon 20 insertions is the [Exon 20 Group](/companies/exon-20-group/). Other biomarker groups here include [ALK Positive](/companies/alk-positive/), [EGFR Resisters](/companies/egfr-resisters/), [The ROS1ders](/companies/the-ros1ders/) and [KRAS Kickers](/companies/kras-kickers/). For broader lung cancer support, see [LUNGevity](/companies/lungevity/) and [GO2 for Lung Cancer](/companies/go2-for-lung-cancer/). My [find support](/resources/find-support/) guide covers how to choose.

## Questions I would ask

- Can you review my testing report and confirm my MET alteration?
- Which trials or compassionate use options fit my situation?
- Can you connect me with a MET Mentor?
- What records should I send before my intake call?

## Contacts

- Website: [metcrusaders.org](https://metcrusaders.org/)
- How to join: [metcrusaders.org/join](https://metcrusaders.org/join/)
- Email: info@metcrusaders.org
- Phone: 602-618-0183

## Limits and context
Program details are reported by the group unless noted, as of October 2026. Confirm current programs, eligibility and any costs directly with the group. A community group does not give medical advice.

## Relationships and disclosures
I have no financial or business relationship with this organization.

## Sources
- [MET Crusaders home page](https://metcrusaders.org/) — MET Crusaders; official; checked 2026-10-22; Global, pan-tumor biomarker support group for MET exon 14 skipping, amplification, overexpression; phone and email; ASCO 2026 recaps.
- [About MET Crusaders](https://metcrusaders.org/about/) — MET Crusaders; official; checked 2026-10-22; Pan-tumor community of MET-altered cancer patients, care partners, oncologists and researchers.
- [What we do](https://metcrusaders.org/what-we-do/) — MET Crusaders; official; checked 2026-10-22; Membership is free; navigation, oncology nursing, second opinion referrals, molecular testing connections, trial and compassionate use matching, MET Mentors, webinars, meet-ups, advocacy training.
- [Join](https://metcrusaders.org/join/) — MET Crusaders; official; checked 2026-10-22; Join by contacting info@metcrusaders.org or 602-618-0183.
- [Marcia K. Horn, JD](https://metcrusaders.org/team/marcia-k-horn-jd/) — MET Crusaders; official; checked 2026-10-22; Chair of MET Crusaders and President/CEO of ICAN; ICAN navigating patients since 1996; lists ICAN's other biomarker groups including the Exon 20 Group.
- [International Cancer Advocacy Network nonprofit record](https://projects.propublica.org/nonprofits/organizations/860818253) — ProPublica Nonprofit Explorer; research; checked 2026-10-22; International Cancer Advocacy Network, Phoenix AZ, EIN 86-0818253, 501(c)(3), exempt since 1996.

Organization website: https://metcrusaders.org/

Organization type: Nonprofit

Services: Connect with peers, Patient education, Patient advocacy, Clinical trial navigation, Research & navigation

Community focus: MET-altered cancer, MET exon 14 skipping, MET amplification, MET overexpression, Caregivers

Information/access: [Join MET Crusaders](https://metcrusaders.org/join/)

Service status: available

## Company facts
- **Who it serves:** People with any MET-altered cancer, in any tumor type, and their care partners. (Sources: home, about)
- **Cost:** As of October 2026, membership and services are free. (Sources: whatwedo)
- **Parent organization:** Part of ICAN, International Cancer Advocacy Network, a 501(c)(3) (EIN 86-0818253). (Sources: horn, propublica)
- **Navigation:** Second opinion referrals, molecular testing connections, clinical trial and compassionate use matching. (Sources: whatwedo)

Topics: getting-started, expert-support, clinical-trials
Capabilities: patient-support, clinical-trials, research-support

Related record IDs: 656030c7-047a-40e9-b47b-14b19f3fd2bd

Follow Kevin on X: https://x.com/kevinace

Educational information, not an individualized treatment recommendation.